BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25629516)

  • 1. IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.
    Mantani PT; Dunér P; Bengtsson E; Alm R; Ljungcrantz I; Söderberg I; Sundius L; To F; Nilsson J; Björkbacka H; Fredrikson GN
    PLoS One; 2015; 10(1):e0117255. PubMed ID: 25629516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions.
    Mantani PT; Dunér P; Ljungcrantz I; Nilsson J; Björkbacka H; Fredrikson GN
    BMC Immunol; 2019 Dec; 20(1):47. PubMed ID: 31823769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis.
    Engelbertsen D; Foks AC; Alberts-Grill N; Kuperwaser F; Chen T; Lederer JA; Jarolim P; Grabie N; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2526-35. PubMed ID: 26494229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
    Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
    Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
    J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.
    Hosseini H; Yi L; Kanellakis P; Cao A; Tay C; Peter K; Bobik A; Toh BH; Kyaw T
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: Preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides.
    Grundtman C; Jakic B; Buszko M; Onestingel E; Almanzar G; Demetz E; Dietrich H; Cappellano G; Wick G
    Atherosclerosis; 2015 Sep; 242(1):303-10. PubMed ID: 26233917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
    Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
    Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet.
    Jeon US; Choi JP; Kim YS; Ryu SH; Kim YK
    Exp Mol Med; 2015 May; 47(5):e163. PubMed ID: 25976521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice.
    Mantani PT; Dunér P; Bengtsson E; Ljungcrantz I; Sundius L; To F; Nilsson J; Björkbacka H; Fredrikson GN
    J Biol Chem; 2018 May; 293(18):6791-6801. PubMed ID: 29572351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
    Smith E; Prasad KM; Butcher M; Dobrian A; Kolls JK; Ley K; Galkina E
    Circulation; 2010 Apr; 121(15):1746-55. PubMed ID: 20368519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
    Cesena FH; Dimayuga PC; Yano J; Zhao X; Kirzner J; Zhou J; Chan LF; Lio WM; Cercek B; Shah PK; Chyu KY
    Atherosclerosis; 2012 Jan; 220(1):59-65. PubMed ID: 22062590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.
    Perry HM; Oldham SN; Fahl SP; Que X; Gonen A; Harmon DB; Tsimikas S; Witztum JL; Bender TP; McNamara CA
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2771-9. PubMed ID: 24115031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression.
    Dietel B; Muench R; Kuehn C; Kerek F; Steinkasserer A; Achenbach S; Garlichs CD; Zinser E
    Atherosclerosis; 2014 Aug; 235(2):263-72. PubMed ID: 24887015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
    Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4.
    Wu C; He S; Liu J; Wang B; Lin J; Duan Y; Gao X; Li D
    Scand J Immunol; 2018 May; 87(5):e12661. PubMed ID: 29570822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.
    Dietrich T; Hucko T; Schneemann C; Neumann M; Menrad A; Willuda J; Atrott K; Stibenz D; Fleck E; Graf K; Menssen HD
    Atherosclerosis; 2012 Feb; 220(2):329-36. PubMed ID: 22062588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Davenport P; Tipping PG
    Am J Pathol; 2003 Sep; 163(3):1117-25. PubMed ID: 12937153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.